NOS1 and status epilepticus: First, clinical characterization of selective nNOS inhibitors and NMDAR/nNOS uncouplers could unlock their potential as powerful treatments for conditions in which excitotoxicity plays an important pathophysiological role, such as status epilepticus, traumatic brain injury, and cerebral ischemia [63].